Overall, mutations in DNMT3A, including DNMT3AR882H, are associated with worse prognosis in AML,4,57 however, both co-mutation patterns, as well as clinical attributes such as age, are also associated with DNMT3A mutations. Here, DNMT3A is linked to acute myeloid leukemia.